SeaStar’s cytopheretic device effective in severe Covid-19 patients, study says
SCD is a patented, cell-directed, extracorporeal immunomodulator that selectively targets activated neutrophils and monocytes to address hyperinflammation
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jun 22
SCD is a patented, cell-directed, extracorporeal immunomodulator that selectively targets activated neutrophils and monocytes to address hyperinflammation
08 Jun 22
CE-IVD certified, IVDR-compliant qPCR system supports new molecular diagnostic manufacturing and testing workflows
08 Jun 22
RhinAer treatment resulted in significant symptom improvement through 24 months in both non-allergic and allergic rhinitis patients
07 Jun 22
With the acquisition, BD is enabled to expand its solutions to provide new pharmacy automation technologies for hospitals,…
07 Jun 22
DEXA SOLO-L is a 3D printed, standalone anterior lumbar interbody fusion and lateral lumbar interbody fusion (ALIF &…
07 Jun 22
ECHELON 3000 is an advanced surgical stapling device that builds upon the ECHELON+ Stapler with GST Reloads, to…
07 Jun 22
Affordable, easy-to-use benchtop system empowers labs of all sizes to both generate and quality control NGS libraries for…
07 Jun 22
The company also announced the appointment of Michael Choukas as Chief Executive Officer
06 Jun 22
The new liquid biopsy panel xF+ is said to be the largest liquid biopsy panel available on the…
06 Jun 22
Largest Gulf South Health System Will Offer GRAIL’s Galleri® Multi-Cancer Early Detection Test to Patients at Risk for…